Arcutis Biotherapeutics, Inc. — SC 13G/A Filings
16 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Arcutis Biotherapeutics, Inc. (ARQT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Arcutis Biotherapeutics, Inc. has filed 16 SC 13G/A documents with the SEC since 2019. To view all SEC filings by Arcutis Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | ARCUTIS BIOTHERAPEUTICS, INC. | 0000902664-24-006650 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-117739 | Nov 13, 2024 | — |
| SC 13G/A | — | 0002012383-24-003468 | Nov 8, 2024 | — |
| SC 13G/A | — | 0002012383-24-001319 | Oct 22, 2024 | — |
| SC 13G/A | 13G AMENDED ANNUAL FILING ARQT | 0000053417-24-000050 | Mar 6, 2024 | — |
| SC 13G/A | — | 0001172661-24-000754 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000919574-24-000965 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-23-002755 | Nov 13, 2023 | — |
| SC 13G/A | — | 0001306550-23-010278 | Nov 7, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000370 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000315066-23-001359 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-007762 | Feb 3, 2023 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-22-000305 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000315066-22-000791 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000834237-22-006328 | Feb 3, 2022 | — |
| SC 13G/A | — | 0000315066-21-000840 | Feb 8, 2021 | — |